Cargando…

Comparison of Efficacy of Intensive versus Mild Pitavastatin Therapy on Lipid and Inflammation Biomarkers in Hypertensive Patients with Dyslipidemia

OBJECTIVE: Intensive as compared to mild statin therapy has been proven to be superior in improving cardiovascular outcome, whereas the effects of intensive statin therapy on inflammation and lipoprotein biomarkers are not well defined. METHODS: This study assigned essential hypertensive patients wi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yamasaki, Tomohiro, Iwashima, Yoshio, Jesmin, Subrina, Ohta, Yuko, Kusunoki, Hiroshi, Hayashi, Shin-ichiro, Horio, Takeshi, Kawano, Yuhei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3929641/ https://www.ncbi.nlm.nih.gov/pubmed/24586502 http://dx.doi.org/10.1371/journal.pone.0089057

Ejemplares similares

Impact of Percutaneous Transluminal Renal Angioplasty on Autonomic Nervous System and Natriuresis in Hypertensive Patients With Renal Artery Stenosis
por: Iwashima, Yoshio, et al.
Publicado: (2022)

Critical appraisal of the role of pitavastatin in treating dyslipidemias and achieving lipid goals
por: Saito, Yasushi
Publicado: (2009)

Pitavastatin approved for treatment of primary hypercholesterolemia and combined dyslipidemia
por: Sasaki, Jun
Publicado: (2010)

Effects of pitavastatin add-on therapy on chronic kidney disease with albuminuria and dyslipidemia
por: Ohsawa, Masato, et al.
Publicado: (2015)

Efficacy and safety of sacubitril/valsartan after switching from azilsartan in hemodialysis patients with hypertension
por: Iwashima, Yoshio, et al.
Publicado: (2023)

Factors Associated with Outcomes of Percutaneous Transluminal Renal Angioplasty in Patients with Renal Artery Stenosis: A Retrospective Analysis of 50 Consecutive Cases
por: Matayoshi, Tetsutaro, et al.
Publicado: (2018)

Effects of Pitavastatin on Lipid Profiles in HIV-Infected Patients with Dyslipidemia and Receiving Atazanavir/Ritonavir: A Randomized, Double-Blind, Crossover Study
por: Wongprikorn, Asita, et al.
Publicado: (2016)

Does Pitavastatin Therapy for Patients with Type 2 Diabetes and Dyslipidemia Affect Serum Adiponectin Levels and Insulin Sensitivity?
por: Lee, Jeongmin, et al.
Publicado: (2022)

Pleiotropic effects of pitavastatin
por: Davignon, Jean
Publicado: (2012)

Comprehensive assessment of metabolic syndrome among rural Bangladeshi women
por: Jesmin, Subrina, et al.
Publicado: (2012)

Interaction of the pitavastatin with model membranes
por: Shurshalova, Guzel S., et al.
Publicado: (2021)

Effects of intensive versus mild lipid lowering by statins in patients with ischemic congestive heart failure: Korean Pitavastatin Heart Failure (SAPHIRE) study
por: Lee, Hae-Young, et al.
Publicado: (2014)

Pitavastatin in cardiometabolic disease: therapeutic profile
por: Masana, Luis
Publicado: (2013)

Efficacy and Safety of Pitavastatin in Children and Adolescents with Familial Hypercholesterolemia in Japan and Europe
por: Harada-Shiba, Mariko, et al.
Publicado: (2018)

Repeated open endotracheal suctioning causes gradual desaturation but does not exacerbate lung injury compared to closed endotracheal suctioning in a rabbit model of ARDS
por: Sakuramoto, Hideaki, et al.
Publicado: (2013)

Activated protein C does not increase in the early phase of trauma with disseminated intravascular coagulation: comparison with acute coagulopathy of trauma-shock
por: Jesmin, Subrina, et al.
Publicado: (2016)

Pitavastatin Compared with Differential Intervention Trial by Standard Therapy on Cardiovascular Events in Patients with Dyslipidemia on Chronic Hemodialysis (DIALYSIS): A Randomized Controlled Trial
por: Hamada, Chieko, et al.
Publicado: (2023)

The Long-Term Effects of Pitavastatin on Blood Lipids and Platelet Activation Markers in Stroke Patients: Impact of the Homocysteine Level
por: Sugimoto, Hideki, et al.
Publicado: (2014)

Effects of pitavastatin on plasminogen activator inhibitor-1 in hyperlipidemic patients
por: Nomura, Shosaku, et al.
Publicado: (2012)

Pitavastatin: evidence for its place in treatment of hypercholesterolemia
por: Alagona, Peter
Publicado: (2010)

Effect of Pitavastatin on Vascular Reactivity in Hypercholesterolemic Rabbits
por: de Almeida, Eros Antonio, et al.
Publicado: (2014)

Efficacy and Safety of Pitavastatin/Ezetimibe Fixed-Dose Combination vs. Pitavastatin: Phase III, Double-Blind, Randomized Controlled Trial
por: Tsujita, Kenichi, et al.
Publicado: (2023)

Direct Evidence for Pitavastatin Induced Chromatin Structure Change in the KLF4 Gene in Endothelial Cells
por: Maejima, Takashi, et al.
Publicado: (2014)

Effects of pitavastatin on atherosclerotic-associated inflammatory biomarkers in people living with HIV with dyslipidemia and receiving ritonavir-boosted atazanavir: a randomized, double-blind, crossover study
por: Srichatrapimuk, Sirawat, et al.
Publicado: (2023)

Statins in cardiometabolic disease: what makes pitavastatin different?
por: Ginsberg, Henry
Publicado: (2013)

Pitavastatin suppressed liver cancer cells in vitro and in vivo
por: You, He-Yi, et al.
Publicado: (2016)

Differential Diabetogenic Effect of Pitavastatin and Rosuvastatin, in vitro and in vivo
por: Cho, Yongin, et al.
Publicado: (2020)

Pitavastatin Is a Highly Potent Inhibitor of T-Cell Proliferation
por: Voss, Linda, et al.
Publicado: (2021)

Using angiogenic factors and their soluble receptors to predict organ dysfunction in patients with disseminated intravascular coagulation associated with severe trauma
por: Wada, Takeshi, et al.
Publicado: (2012)

Efficacy and Safety of Pitavastatin in a Real-World Setting: Observational Study Evaluating SaFety in Patient Treated with Pitavastatin in Korea (PROOF Study)
por: Jeong, In-Kyung, et al.
Publicado: (2020)

Differential Expression, Time Course and Distribution of Four PARs in Rats with Endotoxin-induced Acute Lung Injury
por: Jesmin, Subrina, et al.
Publicado: (2006)

Hyperinflation deteriorates arterial oxygenation and lung injury in a rabbit model of ARDS with repeated open endotracheal suctioning
por: Kamiyama, Junko, et al.
Publicado: (2015)

Benefit–risk assessment of pitavastatin for the treatment of hypercholesterolemia in older patients
por: Chamberlin, Kevin W, et al.
Publicado: (2015)

Chest pain as a possible side effect of pitavastatin (Livalo)
por: AlZahrani, Nada R., et al.
Publicado: (2019)

Conformational Analysis of Geometric Isomers of Pitavastatin Together with Their Lactonized Analogues
por: Makuc, Damjan, et al.
Publicado: (2013)

Pitavastatin Ameliorates Lipopolysaccharide-Induced Blood-Brain Barrier Dysfunction
por: Fujimoto, Takashi, et al.
Publicado: (2021)

Pitavastatin Induces Cancer Cell Apoptosis by Blocking Autophagy Flux
por: Tilija Pun, Nirmala, et al.
Publicado: (2022)

Therapeutic Arteriogenesis/Angiogenesis for Peripheral Arterial Disease by Nanoparticle-Mediated Delivery of Pitavastatin into Vascular Endothelial Cells
por: Matsumoto, Takuya, et al.
Publicado: (2020)

Pitavastatin-Incorporated Nanoparticles for Chronic Limb Threatening Ischemia: A Phase I/IIa Clinical Trial
por: Matsumoto, Takuya, et al.
Publicado: (2022)

Switching to Pitavastatin in Statin-Treated Low HDL-C Patients Further Improves the Lipid Profile and Attenuates Minute Myocardial Damage
por: Ibuki, Chikao, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_f7vdjnrhenv1bmeq7fe3l1balk